Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
Luisa Prochazkova, Dominique P. Lippelt, Lorenza S. Colzato, et al.
Psychopharmacology (2018) Vol. 235, Iss. 12, pp. 3401-3413
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

A systematic study of microdosing psychedelics
Vince Polito, Richard J. Stevenson
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0211023-e0211023
Open Access | Times Cited: 177
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Kim P. C. Kuypers, Livia Ng, David Erritzøe, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1039-1057
Open Access | Times Cited: 171
Metacontrol of human creativity: The neurocognitive mechanisms of convergent and divergent thinking
Weitao Zhang, Zsuzsika Sjoerds, Bernhard Hommel
NeuroImage (2020) Vol. 210, pp. 116572-116572
Open Access | Times Cited: 168
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being
Natasha L. Mason, Elisabeth Mischler, Malin V. Uthaug, et al.
Journal of Psychoactive Drugs (2019) Vol. 51, Iss. 2, pp. 123-134
Open Access | Times Cited: 148
Self-blinding citizen science to explore psychedelic microdosing
Balázs Szigeti, Laura Kärtner, Allan Blemings, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 138
Naming unrelated words predicts creativity
Jay A. Olson, Johnny Nahas, Denis Chmoulevitch, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 25
Open Access | Times Cited: 123
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
Laura Kaertner, Michael B. Steinborn, Hannes Kettner, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 111
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 110
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Federico Cavanna, Stephanie Müller, Laura Alethia de la Fuente, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field
Vince Polito, Paul Liknaitzky
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104706-104706
Open Access | Times Cited: 70
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 2
Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers
Anya K. Bershad, Scott T. Schepers, Michael P. Bremmer, et al.
Biological Psychiatry (2019) Vol. 86, Iss. 10, pp. 792-800
Open Access | Times Cited: 137
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron, Charlie J. Benson, Brian C. DeFelice, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3261-3270
Open Access | Times Cited: 136
Tripping on nothing: placebo psychedelics and contextual factors
Jay A. Olson, Léah Suissa-Rocheleau, Michael Lifshitz, et al.
Psychopharmacology (2020) Vol. 237, Iss. 5, pp. 1371-1382
Closed Access | Times Cited: 108
Motives and Side-Effects of Microdosing With Psychedelics Among Users
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
The International Journal of Neuropsychopharmacology (2019) Vol. 22, Iss. 7, pp. 426-434
Open Access | Times Cited: 100
Psychedelic microdosing benefits and challenges: an empirical codebook
Thomas Anderson, Rotem Petranker, Adam Christopher, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 98
Spontaneous and deliberate creative cognition during and after psilocybin exposure
Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 97
Psychedelic Microdosing: A Subreddit Analysis
Toby Lea, Nicole Amada, Henrik Jungaberle
Journal of Psychoactive Drugs (2019) Vol. 52, Iss. 2, pp. 101-112
Closed Access | Times Cited: 90
Microdosing psychedelics: Motivations, subjective effects and harm reduction
Toby Lea, Nicole Amada, Henrik Jungaberle, et al.
International Journal of Drug Policy (2019) Vol. 75, pp. 102600-102600
Closed Access | Times Cited: 86
Psychedelic Microdosing: Prevalence and Subjective Effects
Lindsay P. Cameron, Angela Nazarian, David E. Olson
Journal of Psychoactive Drugs (2020) Vol. 52, Iss. 2, pp. 113-122
Open Access | Times Cited: 83
Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism
Marcus W. Meinhardt, Simone Pfarr, Grégory Fouquet, et al.
Science Advances (2021) Vol. 7, Iss. 47
Open Access | Times Cited: 71
Simulated visual hallucinations in virtual reality enhance cognitive flexibility
Clara Rastelli, Antonino Greco, Yoed N. Kenett, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
Steven A. Barker
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1749-1763
Open Access | Times Cited: 38
Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review
Jan Lazur, Kamil Hnatyk, Katarzyna Kała, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 623-623
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top